Table 1.

The TCGA and Singapore cohorts

	Tumor samples			Normal samples
Cohorts	Train	Validation	Test	Train	Validation	Test
BRCA	559	185	185	76	27	30
GBM	285	95	94	0	0	0
KIRC	261	85	89	220	71	73
LGG	273	91	90	0	0	0
LUAD	266	90	90	101	37	33
LUSC	273	90	90	132	41	47
OV	310	103	103	53	13	18
PRAD	258	85	85	72	15	24
THCA	258	85	85	48	18	17
UCEC	270	90	89	18	4	10
LUAD_SG	107	36	36	0	0	0

In each cohort, a patient has only one tumor sample and one matching normal sample, if available. The numbers of tumor and matching normal samples in training, validation, and test sets are presented for each cohort. The data are segregated at the patient level. See also Tables S1 and S2, Figures S1–S3, and Note S1.